A detailed history of Newfound Research LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Newfound Research LLC holds 353 shares of BDX stock, worth $79,011. This represents 0.19% of its overall portfolio holdings.

Number of Shares
353
Previous 408 13.48%
Holding current value
$79,011
Previous $101,000 21.78%
% of portfolio
0.19%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$51.03 - $264.23 $2,806 - $14,532
-55 Reduced 13.48%
353 $79,000
Q2 2022

Jul 15, 2022

SELL
$234.74 - $275.42 $18,309 - $21,482
-78 Reduced 16.05%
408 $101,000
Q1 2022

May 04, 2022

BUY
$243.64 - $270.48 $2,192 - $2,434
9 Added 1.89%
486 $129,000
Q4 2021

Jan 19, 2022

BUY
$230.08 - $250.94 $55,679 - $60,727
242 Added 102.98%
477 $120,000
Q3 2021

Oct 14, 2021

BUY
$232.72 - $256.47 $54,689 - $60,270
235 New
235 $58,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.